$heff's $tation of $tocks & $olid DD

[legacyinvestor]

CHTP New article in SA. It gives trading ideas for every scenario. One thing I didn't know that it mentions is that "In the second panel meeting, FDA lamented the conduct of Study 301 in Eastern Europe. Specifically, two sites that contributed the most positive data have clearly faked the records.
A second CRL would likely be a death penalty for this tiny company"

Any thoughts on this? I have been thinking about more calls before PDUFA, but that's a little worrying. Thanks for any comments!